M. R. Mozafari


Australasian Nanoscience and Nanotechnology Initiative, Monash University, Clayton, Victoria 3168, Australia

Head of R&D Supreme NanoBiotics Co. Ltd. and Supreme Pharmatech Co. Ltd., 399/90-95 Moo 13 Kingkaew Rd. Soi 25/1, T. Rachateva, A. Bangplee, Samutprakan 10540, Thailand

President & Founder Australasian Nanoscience and Nanotechnology Initiative, Monash University, Melbourne, Australia (2009 – Present). Development of a novel drug delivery system for the encapsulation and controlled release of therapeutic agents. Called "Tocosome", the new carrier system is mainly composed of tocopheryl phosphates. Preliminary data published in "International Journal of Pharmaceutics“ as “Rapid Communication” due to the importance of the study (2017). Encapsulation of the anticancer agent 5-fluorouracil in Nanoliposomes and Tocosomes using "Mozafari method" without employing toxic solvents, detergents or harsh treatments such as homogenization or sonication. Data published in peer-reviewed journals. Formulation of polyunsaturated fatty acids in a nanoliposome system prepared by "Mozafari method". Research findings published in peer-reviewed journals. Developed a liposomal anti-aging skin-care cream. Formulation of liposomal creams and lotions for eczema and psoriasis; a nasal formulation of fentanyl; and an oral formulation of fenofibrate. The drug delivery systems were prepared by “Mozafari method” as well as some conventional techniques. Various In Vitro and In Vivo assays and tests were employed for the analysis and optimization of the formulated samples. Lecturing and presentations at national and international conferences

Expert in Nano-biotechnology, Theranostic Drug Delivery, Encapsulation, Targeting and Controlled Release of Bio-active agents, Food supplements and Nutraceuticals with substantial number of publications, 11 Patents, 5 Books and several Book-chapters. A pioneer in the field of Nano-Carrier systems (author of the first book on Nanoliposomes), have developed methods (including “Mozafari Method” and “Heating Method”) for largescale manufacture of controlled-release, drug delivery systems without using toxic agents (e.g. volatile solvents, detergents, etc.). Have several years experience of lecturing internationally, drafting patent applications as well as working in GMP environments.